To assess the clinical value of GRK3 expression in colon cancer patients survival, Kaplan-Meier curves with a log-rank test for overall survival (OS) and disease-free survival (DFS) were undertaken. The gene discussed is GRK3; the disease is malignant colon neoplasm.